Nitromed, Inc.
Records under this name other than patents Nitromed, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,754,772 | Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 8,067,414 | Nitric Oxide Enhancing Prostaglandin Compounds, Compositions and Methods of Use Formerly held In force · High confidence | In force | High confidence | |
| US 8,846,674 | Nitric Oxide Enhancing Prostaglandin Compounds, Compositions and Methods of Use Formerly held Lapsed on the fee record Ended Sep 30, 2026 · High confidence | Lapsed on the fee record | Ended Sep 30, 2026 | High confidence |
| US 8,304,409 | Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use Formerly held Term ended Term ended Dec 24, 2023 · From the USPTO record | Term ended | Term ended Dec 24, 2023 | From the USPTO record |
| US 7,163,958 | Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use Formerly held Term ended Term ended Jul 3, 2023 · From the USPTO record | Term ended | Term ended Jul 3, 2023 | From the USPTO record |
| US 7,883,714 | Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use Formerly held Term ended Term ended Jul 3, 2023 · From the USPTO record | Term ended | Term ended Jul 3, 2023 | From the USPTO record |
| US 8,088,762 | Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use Formerly held Term ended Term ended Jul 3, 2023 · From the USPTO record | Term ended | Term ended Jul 3, 2023 | From the USPTO record |
| US 8,222,277 | Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use Formerly held Term ended Term ended Jul 3, 2023 · From the USPTO record | Term ended | Term ended Jul 3, 2023 | From the USPTO record |
| US 6,784,177 | Methods of Treating and Preventing Congestive Heart Failure with Hydralazine Compounds and Isosorbide Dinitrate or Isosorbide Mononitrate Formerly held Term ended Ended no later than Aug 20, 2022 · Medium confidence | Term ended | Ended no later than Aug 20, 2022 | Medium confidence |
| US 7,556,824 | A Transdermal Patch Composition for Treating Vascular Diseases Characterized by Nitric Oxide Insufficiency Term ended Term ended Aug 2, 2022 · Medium confidence | Term ended | Term ended Aug 2, 2022 | Medium confidence |